A review of the amyloidoses that infiltrate the heart
- PMID: 9702380
- PMCID: PMC6655639
- DOI: 10.1002/clc.4960210804
A review of the amyloidoses that infiltrate the heart
Abstract
Primary amyloidosis, systemic senile amyloidosis, isolated atrial amyloidosis, and transthyretin isoleucine 122 amyloidosis frequently involve the heart. Amyloid fibrils infiltrate the myocardium, impairing ventricular contraction and relaxation. The clinical manifestations of cardiac infiltration in these disorders are protean, though congestive heart failure and arrhythmias are most common. Treatment of cardiac amyloidosis is directed at the underlying cause and at relief of symptoms. Heart transplantation is not a viable treatment option for patients with primary amyloidosis; its role in the other amyloidoses has not been established. The prognosis of patients with cardiac amyloidosis varies and is largely determined by the underlying disorder responsible for amyloid infiltration.
Similar articles
-
Cardiac amyloidosis: a practical approach to diagnosis and management.Am J Med. 2011 Nov;124(11):1006-15. doi: 10.1016/j.amjmed.2011.04.013. Am J Med. 2011. PMID: 22017778 Review.
-
Current trends in diagnosis and management of cardiac amyloidosis.Curr Probl Cardiol. 2013 Feb;38(2):53-96. doi: 10.1016/j.cpcardiol.2012.11.002. Curr Probl Cardiol. 2013. PMID: 23337445 Review.
-
[Cardiac amyloidosis].Med Klin (Munich). 2008 Mar 15;103(3):153-60. doi: 10.1007/s00063-008-1022-2. Med Klin (Munich). 2008. PMID: 18344065 Review. German.
-
[Heart failure in amyloidosis--a rare but treatable disease].Lakartidningen. 2002 May 23;99(21):2386-8, 2391. Lakartidningen. 2002. PMID: 12090165 Swedish.
-
Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.Br Heart J. 1993 Aug;70(2):111-5. doi: 10.1136/hrt.70.2.111. Br Heart J. 1993. PMID: 8038017 Free PMC article. Review.
Cited by
-
Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.PLoS One. 2009;4(1):e4124. doi: 10.1371/journal.pone.0004124. Epub 2009 Jan 6. PLoS One. 2009. PMID: 19125186 Free PMC article.
-
Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14545-50. doi: 10.1073/pnas.0501609102. Epub 2005 Sep 29. Proc Natl Acad Sci U S A. 2005. PMID: 16195386 Free PMC article.
-
Amyloid in the cardiovascular system: a review.J Clin Pathol. 2005 Feb;58(2):125-33. doi: 10.1136/jcp.2004.017293. J Clin Pathol. 2005. PMID: 15677530 Free PMC article. Review.
-
A case of a senile systemic amyloidosis patient presenting with angina pectoris and dilated cardiomyopathy.Korean Circ J. 2011 Apr;41(4):209-12. doi: 10.4070/kcj.2011.41.4.209. Epub 2011 Apr 30. Korean Circ J. 2011. PMID: 21607172 Free PMC article.
-
Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis.Circ Cardiovasc Imaging. 2018 May;11(5):e006588. doi: 10.1161/CIRCIMAGING.117.006588. Circ Cardiovasc Imaging. 2018. PMID: 29752392 Free PMC article.
References
-
- Glenner GG: Amyloid deposits and amyloidosis. The β‐fibrilloses. N Engl J Med 1980; 302: 1283–1290; 1333–1341 - PubMed
-
- Stevens FJ, Myatt EA, Chang CH, Westholm FA. Eulitz M, Weiss DT, Murphy C, Solomon A, Schiffer M: A molecular model for self‐assembly of amyloid fibrils: Immunoglobulin light chains. Biochemistry 1995; 34: 10697–10702 - PubMed
-
- Smith RR, Hutchins GM: Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. Am J Cardiol 1979; 44: 413–417 - PubMed
-
- Ridolfi BL, Bulkley BH, Hutchins GM: The conduction system in cardiac amyloidosis: Clinical and pathologic features of 23 patients. Am J Med 1977; 62: 677–686 - PubMed
-
- Garcia R, Saeed SM: Amyloidosis: Cardiovascular manifestations in five illustrative cases. Arch Intern Med 1968; 121: 259–266 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials